Federated Hermes’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-3
Closed -$1K 2314
2019
Q4
$1K Buy
+3
New +$703 ﹤0.01% 2119
2019
Q2
Sell
-79
Closed -$18K 2195
2019
Q1
$18K Buy
+79
New +$17.9K ﹤0.01% 1793
2018
Q4
Sell
-21
Closed -$4K 2262
2018
Q3
$4K Sell
21
-48
-70% -$9.66K ﹤0.01% 2087
2018
Q2
$15K Buy
+69
New +$12.1K ﹤0.01% 1846
2016
Q3
Sell
-78
Closed -$10K 2147
2016
Q2
$10K Buy
+78
New +$8.4K ﹤0.01% 1811
2015
Q4
Sell
-136
Closed -$15K 2127
2015
Q3
$15K Buy
136
+2
+1% +$211 ﹤0.01% 1697
2015
Q2
$12K Buy
+134
New +$11.3K ﹤0.01% 1709
2014
Q3
Sell
-62
Closed -$5K 2035
2014
Q2
$5K Buy
+62
New +$5.13K ﹤0.01% 1828

Other funds holding MLAB

Federated Hermes's MLAB Position: Q1 2020 in Review

Federated Hermes sold out of Mesa Laboratories (MLAB) in Q1 2020, closing a stake of 3 shares — an estimated $1K sold.

Federated Hermes first reported a position in MLAB in Q2 2014 and held it in 8 quarters. The position peaked at $18K in Q1 2019. 145 funds tracked by Wall St. Rank hold MLAB as of Q1 2020.

  • Federated Hermes reported no remaining Mesa Laboratories position as of Q1 2020 after selling out during the quarter.
  • Federated Hermes sold 3 Mesa Laboratories shares in Q1 2020, an estimated $1K.
  • Federated Hermes first reported a position in Mesa Laboratories in Q2 2014 and held it in 8 quarters.
  • Federated Hermes's Mesa Laboratories position peaked at $18K in Q1 2019.
  • 145 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2020.

Based on Federated Hermes's 13F filing for Q1 2020, filed 13 May 2020.